Literature DB >> 9617642

Myocardial iron deposition in beta-thalassemia studied by magnetic resonance imaging.

S I Mavrogeni1, T Maris, A Gouliamos, L Vlahos, D T Kremastinos.   

Abstract

Myocardial iron deposition is a common finding in beta-thalassemia. The iron content of the myocardium was assessed using the T2 relaxation time of the heart. The T2 relaxation time of the liver and skeletal muscle was also assessed in order to study the relation of iron deposition between heart, liver and skeletal muscle. ECG gated spin echo images were obtained from thirty-eight consecutive adult thalassemic patients examined in an outpatient clinic, aged (x +/- SD) 25 +/- 6 years, using a 0.5 T system. Patients were divided into groups A and B, according to their average serum ferritin levels of the preceding five years (> or < 2000 ng/ml). Results were compared with nine controls, aged 24 +/- 7 years. Heart T2 relaxation time in the control group (x +/- SD) (48.3 +/- 5.5 msec) was higher compared to group A (28.4 +/- 6.7 msec, p < 0.001) but not to group B (43.4 +/- 7.4 msec). The T2 relaxation time of the heart correlated positively with the T2 relaxation time of the liver (r = 0.68, p < 0.001) and negatively with ferritin levels (r = -0.67, p < 0.001). There was no correlation with the T2 relaxation time of skeletal muscle. This study indicates that regularly transfused beta-thalassemia patients may present with a broad variation of heart iron deposition which, however, is related to serum ferritin levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9617642     DOI: 10.1023/a:1005922016048

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  23 in total

1.  T1 and T2 of ferritin at different field strengths: effect on MRI.

Authors:  J Vymazal; R A Brooks; O Zak; C McRill; C Shen; G Di Chiro
Journal:  Magn Reson Med       Date:  1992-10       Impact factor: 4.668

2.  CARDIAC INVOLVEMENT IN COOLEY'S ANEMIA.

Authors:  M A ENGLE
Journal:  Ann N Y Acad Sci       Date:  1964-10-07       Impact factor: 5.691

3.  "Normal" serum ferritin--a caution.

Authors:  R Green; L R Watson; G A Saab; W H Crosby
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

4.  Continuous subcutaenous administration of deferoxamine in patients with iron overload.

Authors:  R D Propper; B Cooper; R R Rufo; A W Nienhuis; W F Anderson; H F Bunn; A Rosenthal; D G Nathan
Journal:  N Engl J Med       Date:  1977-08-25       Impact factor: 91.245

5.  MR relaxation times and iron content of thalassemic spleens: an in vitro study.

Authors:  J M Gomori; R I Grossman; H R Drott
Journal:  AJR Am J Roentgenol       Date:  1988-03       Impact factor: 3.959

6.  Computed tomography scanning of the liver to determine efficacy of iron chelation therapy in thalassemia major.

Authors:  N F Olivieri; D Grisaru; A Daneman; D J Martin; V Rose; M H Freedman
Journal:  J Pediatr       Date:  1989-03       Impact factor: 4.406

7.  Correlation between computed tomographic values and liver iron content in thalassaemia major with iron overload.

Authors:  M T Houang; X Arozena; A Skalicka; E R Huehns; D G Shaw
Journal:  Lancet       Date:  1979-06-23       Impact factor: 79.321

8.  Binding of serum ferritin to concanavalin A: patients with homozygous beta thalassaemia and transfusional iron overload.

Authors:  M Worwood; S J Cragg; A Jacobs; C McLaren; C Ricketts; J Economidou
Journal:  Br J Haematol       Date:  1980-11       Impact factor: 6.998

9.  Survival in medically treated patients with homozygous beta-thalassemia.

Authors:  N F Olivieri; D G Nathan; J H MacMillan; A S Wayne; P P Liu; A McGee; M Martin; G Koren; A R Cohen
Journal:  N Engl J Med       Date:  1994-09-01       Impact factor: 91.245

10.  Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine.

Authors:  M A Aldouri; B Wonke; A V Hoffbrand; D M Flynn; M Laulicht; L A Fenton; P J Scheuer; C C Kibbler; C A Allwood; D Brown
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

View more
  9 in total

1.  Echocardiographic and electrocardiographic prognostic factors of heart failure in young patients with beta-thalassemia major: a 10-year (1995--2004) follow-up.

Authors:  Christina Chrysohoou; Demosthenes B Panagiotakos; Yannis Barbetseas; Stella Brilli; Spyros Lambrou; Markissia Karagiorga; Vassilis A Ladis; Christos Pitsavos; Christodoulos Stefanadis
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

2.  Early detection of cardiac iron deposition in patients with thallassemia, what is the best strategy?

Authors:  L H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2008-08-12       Impact factor: 2.357

Review 3.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

4.  Myocardial and hepatic T2* magnetic resonance evaluation in ex-thalassemic patients after bone-marrow transplantation.

Authors:  Sophie Mavrogeni; Efstathios D Gotsis; Eleni Berdousi; Vasilios Ladis; Dimitrios Verganelakis; Panagiotis Toulas; Dennis V Cokkinos
Journal:  Int J Cardiovasc Imaging       Date:  2007-01-19       Impact factor: 2.357

5.  Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major.

Authors:  Sophie Mavrogeni; Efstathios Gotsis; Vassilios Ladis; Eleni Berdousis; Dimitrios Verganelakis; Panagiotis Toulas; Dennis V Cokkinos
Journal:  Int J Cardiovasc Imaging       Date:  2008-06-26       Impact factor: 2.357

Review 6.  Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases.

Authors:  John C Wood; Nilesh Ghugre
Journal:  Hemoglobin       Date:  2008       Impact factor: 0.849

7.  Effect of iron overload on exercise capacity in thalassemic patients with heart failure.

Authors:  Sophie Mavrogeni; Efstathios Gotsis; Dimitrios Verganelakis; Eleni Berdousis; Athanasios Dritsas; Genovefa Kolovou; Panagiotis Toulas; Vassilios Ladis
Journal:  Int J Cardiovasc Imaging       Date:  2009-08-13       Impact factor: 2.357

8.  Association of iron overload based quantitative T2* MRI technique and carotid intima-media thickness in patients with beta-thalassemia: a cross-sectional study.

Authors:  Shahram Akhlaghpoor; Morteza Hoseini; Amirhosein Jafarisepehr
Journal:  BMC Cardiovasc Disord       Date:  2010-12-31       Impact factor: 2.298

9.  The value of magnetic resonance imaging in evaluation of myocardial and liver iron overload in a thalassaemia endemic population: a report from Northeastern Thailand.

Authors:  Narumol Chaosuwannakit; Pattarapong Makarawate
Journal:  Pol J Radiol       Date:  2019-05-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.